Healthcare -
Biotechnology - NASDAQ - CH
$ 41.63
1.37 %
$ 3.6 B
Market Cap
-8.59
P/E
CRSP - CASH FROM OPERATIONS
Cash from Operations CRSP - CRISPR Therapeutics AG
-143 M
LAST VALUE
46.33%
2 YEAR CAGR
-28.61%
5 YEAR CAGR
-40.41%
10 YEAR CAGR